U.S. flag

An official website of the United States government

NM_022168.4(IFIH1):c.2019_2020del (p.Asp673fs) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 15, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001373304.5

Allele description [Variation Report for NM_022168.4(IFIH1):c.2019_2020del (p.Asp673fs)]

NM_022168.4(IFIH1):c.2019_2020del (p.Asp673fs)

Gene:
IFIH1:interferon induced with helicase C domain 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2q24.2
Genomic location:
Preferred name:
NM_022168.4(IFIH1):c.2019_2020del (p.Asp673fs)
HGVS:
  • NC_000002.12:g.162277440_162277441del
  • NG_011495.1:g.46090_46091del
  • NM_022168.4:c.2019_2020delMANE SELECT
  • NP_071451.2:p.Asp673fs
  • LRG_1235t1:c.2019_2020del
  • LRG_1235:g.46090_46091del
  • LRG_1235p1:p.Asp673fs
  • NC_000002.11:g.163133949_163133950del
  • NC_000002.11:g.163133950_163133951del
Protein change:
D673fs
Links:
dbSNP: rs2105197403
NCBI 1000 Genomes Browser:
rs2105197403
Molecular consequence:
  • NM_022168.4:c.2019_2020del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Singleton-Merten syndrome 1 (SGMRT1)
Synonyms:
Widened medullary cavities of bone, aortic calcification, abnormal dentition, and muscular weakness; Syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition
Identifiers:
MONDO: MONDO:0024535; MedGen: C4225427; Orphanet: 85191; OMIM: 182250
Name:
Aicardi-Goutieres syndrome 7 (AGS7)
Identifiers:
MONDO: MONDO:0014367; MedGen: C3888244; Orphanet: 51; OMIM: 615846

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001570013Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 15, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001570013.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1063467). This variant has not been reported in the literature in individuals affected with IFIH1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp673Glufs*9) in the IFIH1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in IFIH1 cause disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024